Pacific Biosciences Of California (PACB) Equity Ratio (2010 - 2026)

Pacific Biosciences Of California's Equity Ratio history runs 17 years deep, the most recent figure standing at 0.0 for Q1 2026.

• In Q1 2026, Equity Ratio fell 97.16% year-over-year to 0.0; the TTM figure through Mar 2026 stood at 0.0 (down 97.16% YoY), while the FY2025 annual figure was 0.01, down 98.3% from the prior year.
• Equity Ratio was 0.0 for Q1 2026 at Pacific Biosciences Of California, down from 0.01 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.4 in Q3 2023 to a low of 0.0 in Q1 2026.
• Historically, Equity Ratio has averaged 0.27 across 5 years, with a median of 0.34 in 2022.
• The sharpest annual moves came in 2022 and 2025: Equity Ratio jumped 75.33% in 2022, then slumped 98.3% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.32 in 2022, then grew by 26.09% to 0.4 in 2023, then increased by 0.06% to 0.4 in 2024, then plunged by 98.3% to 0.01 in 2025, then plunged by 55.67% to 0.0 in 2026.
• The last three Equity Ratio figures came in at 0.0 (Q1 2026), 0.01 (Q4 2025), and 0.04 (Q3 2025), per Business Quant data.